Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea
抑制肠道顶端 cAMP/cGMP 转运蛋白 (MRP4) 诱发腹泻
基本信息
- 批准号:9025775
- 负责人:
- 金额:$ 33.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-01-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:Abdominal PainAddressAffectApicalApplications GrantsAttentionAttenuatedCell membraneCellsChloride ChannelsChloride IonChloridesChronic DiseaseColitisColonCoupledCouplesCouplingCrohn&aposs diseaseCyclic AMPCyclic GMPCystic Fibrosis Transmembrane Conductance RegulatorDiarrheaDiseaseDistal part of ileumEpithelialEpithelial CellsEuropeFluids and SecretionsFundingGastrointestinal tract structureGenerationsGoalsHealthHealthcareHigh PrevalenceHumanIn VitroIndividualInflammationInflammatory Bowel DiseasesKnockout MiceMacromolecular ComplexesMethodsModelingMucous MembraneNOS2A geneNitric OxideNorth AmericaP-GlycoproteinsPDZ proteinPathway interactionsPharmaceutical PreparationsPhenotypePredispositionProcessProductionProteinsReportingResearchResourcesScaffolding ProteinSignal TransductionSodium Dextran SulfateSusceptibility GeneSymptomsTestingTherapeutic InterventionTissuesUlcerative ColitisUnited Statesapical membraneclinically relevantcommon symptomdisease phenotypegastrointestinal epitheliummolecular assembly/self assemblynoveloverexpressionprotein protein interactionsodium-hydrogen exchanger regulatory factor
项目摘要
DESCRIPTION (provided by applicant): This application for continued support will focus on studying how protein-protein interactions among the cystic fibrosis transmembrane conductance regulator (CFTR), multidrug resistance protein 4 (MRP4) and inducible nitric oxide synthase (iNOS) contribute to the diarrheal symptom observed in Ulcerative Colitis (UC). Our unifying hypothesis is that CFTR, NHERF2, MRP4 and iNOS form a macromolecular complex at or near the plasma membrane in gut epithelial in UC and this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. Specifically, we proposed that iNOS is overexpressed at the plasma membrane of gut epithelia in UC, resulting in the production of sustained high level of nitric oxide (NO) which triggers NO-cGMP pathway and generates compartmentalized cGMP. Since iNOS forms a macromolecular complex with CFTR, NHERF2 and MRP4 at or near the plasma membrane, this NO-dependent compartmentalized cGMP triggers the hyperactivation of CFTR chloride channels and thus causes diarrhea phenotype. Disruption of the macromolecular complex will abolish the functional coupling of iNOS-dependent cGMP generation and CFTR Cl- channel function. The specific aims of this proposal are: Specific Aim 1. To test the hypothesis that iNOS is overexpressed in UC-affected human gut epithelia and to test whether it is coupled to CFTR and MRP4 and upregulates CFTR Cl- channel function Specific Aim 2. To test the hypothesis that iNOS, CFTR, and MRP4 form a macromolecular complex at or near the plasma membrane of gut epithelial cells and that this macromolecular complex is required for the pathogenic process of diarrhea observed in UC. The proposed studies will not only help us better understand the mechanisms underlying the diarrhea symptom commonly observed in UC, but probably provide novel targets and methods for therapeutic interventions of the disease. Therefore, the studies proposed in this application will have clinical relevance for many individuals suffering from UC and also for those suffering from certain forms of secretory diarrheas.
描述(由申请人提供):本持续支持申请将重点研究囊性纤维化跨膜传导调节因子(CFTR)、多药耐药蛋白4(MRP 4)和诱导型一氧化氮合酶(iNOS)之间的蛋白质-蛋白质相互作用如何促进溃疡性结肠炎(UC)中观察到的结肠炎症状。我们的统一假设是,CFTR、NHERF 2、MRP 4和iNOS在UC中肠上皮细胞的质膜处或附近形成大分子复合物,并且该大分子复合物是在UC中观察到的腹泻的致病过程所需的。具体而言,我们提出,在UC中,iNOS在肠上皮细胞的质膜上过表达,导致产生持续高水平的一氧化氮(NO),其触发NO-cGMP通路并产生区室化cGMP。由于iNOS与CFTR、NHERF 2和MRP 4在质膜处或附近形成大分子复合物,因此这种NO依赖性区室化cGMP触发CFTR氯离子通道的超活化,从而引起腹泻表型。大分子复合物的破坏将消除iNOS依赖性cGMP产生和CFTR Cl-通道功能的功能偶联。该提案的具体目标是:具体目标1。为了检验iNOS在UC影响的人肠上皮细胞中过表达的假设,并检验其是否与CFTR和MRP 4偶联并上调CFTR Cl-通道功能。检验以下假设:iNOS、CFTR和MRP 4在肠上皮细胞质膜处或附近形成大分子复合物,并且该大分子复合物是UC中观察到的腹泻致病过程所必需的。这些研究不仅有助于我们更好地了解UC常见腹泻症状的机制,而且可能为疾病的治疗干预提供新的靶点和方法。因此,本申请中提出的研究将对许多患有UC的个体以及患有某些形式的分泌性胃炎的个体具有临床相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anjaparavanda P Naren其他文献
Anjaparavanda P Naren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anjaparavanda P Naren', 18)}}的其他基金
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10406127 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10454293 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR
CFTR校正器在拯救Delta F508-CFTR中的作用机制研究
- 批准号:
10656430 - 财政年份:2020
- 资助金额:
$ 33.35万 - 项目类别:
Personalized Cystic Fibrosis Therapy and Research Center
个性化囊性纤维化治疗和研究中心
- 批准号:
10672704 - 财政年份:2018
- 资助金额:
$ 33.35万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.35万 - 项目类别:
Research Grant